Aredia, Pamidronate Newswire
Comprehensive Real-Time News Feed for Aredia, Pamidronate (generic).
Results 1 - 7 of 7 in Aredia, Pamidronate (generic)
Stephanie Smith is kneeling beside daughter, Mandalynn Smith, who is laying in a hospital bed at Children's Hospital of Alabama during an infusion of pamidronate, a drug in the bisphosphonate family, used to treat bone diseases, as part of UAB's Undiagnosed Diseases Program, 2015. Stephanie Smith's third child, Gage, was different from the start. Comment?
Bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer. Comment?
Fast Market Research recommends "Shenzhen Salubris Pharmaceuticals Co., Ltd. - Financial and Strategic SWOT Analysis Review" from GlobalData, now available Shenzhen Salubris Pharmaceuticals Co., Ltd. is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company's Cardiovascular and other specialty products include allie medoxomil, injection bivalirudin, clopidogrel bisulfate tablets, benazepril hydrochloride tablets, pamidronate disodium injection and desloratadine tablets. Comment?
Malignancy with bone metastases is common in patients with advanced tumor like breast cancer, lung cancer, prostate cancer and multiple myeloma. Since patients with breast cancer or prostate cancer have relatively long median survival time, they still face the problem of treating bone metastases. Comment?
MARK COLVIN: A growing number of former and serving defence force personnel exposed to toxic jet fuel are calling on Defence and the Veteran's Affairs Department to review how they award compensation. There's growing scientific evidence that links fuel exposure to a range of blood cancers. Comment?
The risk of osteonecrosis of the jaw is highest in association with intravenous bisphosphonate use, according to a study published online Aug. 19 in the Journal of Bone and Mineral Research . Xiaoyan Zhang, M.D., Ph.D., from the College of Pharmacy at the University of Florida in Orlando, and colleagues analyzed ONJ cases and associated drugs in the U.S. Food and Drug Administration's adverse event reporting system . Comment?
- « Previous
- Next »
Copyright © 2016 Topix LLC